Tumour-on-a-Chip Systems to Advance Targeted LNP Delivery for mRNA Therapeutics

• Explore how tumour-on-a-chip platforms provide physiologically relevant models to test LNP targeting and efficacy
• Review case studies demonstrating improved predictability of delivery outcomes compared to conventional in vitro assays
• Understand how these systems accelerate candidate optimization and reduce translational risks in oncology applications

Speakers:

Roland Brock

Professor of Biochemistry

Radboud University Medical Center